Zhao-Yi Wang Selected Research

Zhao-Yi Wang Research Topics

Disease

28	Breast Neoplasms (Breast Cancer) 01/2018 - 03/2002
17	Neoplasms (Cancer) 11/2016 - 03/2002
8	Carcinogenesis 09/2011 - 11/2006
6	Wilms Tumor (Wilm's Tumor) 01/2011 - 07/2003
6	Retinoblastoma (Glioblastoma, Retinal) 09/2007 - 07/2003
4	Endometrial Neoplasms (Endometrial Cancer) 09/2011 - 09/2009
3	Carcinoma (Carcinomatosis) 11/2011 - 03/2002
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2021
1	Astigmatism 01/2021
1	Cataract (Cataracts) 01/2021
1	Digestive System Diseases 01/2021
1	Edema (Dropsy) 01/2021
1	Fatty Liver 01/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Neoplasm Metastasis (Metastasis) 10/2014
1	Hypersensitivity (Allergy) 06/2013
1	Prostatic Neoplasms (Prostate Cancer) 10/2012
1	Triple Negative Breast Neoplasms 11/2011
1	Adenoid Cystic Carcinoma (Cylindroma) 01/2011
1	Breast Diseases (Breast Disease) 09/2007
1	Acute Promyelocytic Leukemia 03/2002
1	Wounds and Injuries (Trauma) 01/2002

Drug/Important Bio-Agent (IBA)

17	Estrogens (Estrogen)FDA Link 01/2018 - 03/2002
11	Estrogen ReceptorsIBA 12/2015 - 03/2002
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2003
9	Tamoxifen FDA LinkGeneric 01/2016 - 02/2010
5	Small Interfering RNA (siRNA)IBA 01/2015 - 09/2009
5	Estrogen Receptor Modulators (Antiestrogen)IBA 10/2014 - 01/2008
5	Estrogen Receptor alphaIBA 06/2012 - 03/2002
5	WT1 ProteinsIBA 01/2011 - 09/2003
4	Growth InhibitorsIBA 08/2013 - 07/2003
3	ErbB Receptors (EGF Receptor)IBA 08/2013 - 09/2010
3	Androgen Receptors (Androgen Receptor)IBA 10/2012 - 09/2009
3	Phosphotransferases (Kinase)IBA 11/2010 - 11/2003
3	human estrogen receptor alpha 36IBA 02/2010 - 01/2008
3	Histones (Histone)IBA 09/2007 - 11/2003
3	beta CateninIBA 09/2007 - 09/2003
3	AgarIBA 09/2003 - 07/2003
2	broussoflavonol BIBA 08/2013 - 05/2013
2	Antineoplastic Agents (Antineoplastics)IBA 08/2013 - 05/2011
2	Epidermal Growth Factor (EGF)IBA 01/2012 - 09/2011
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 09/2011 - 05/2011
2	Protein Isoforms (Isoforms)IBA 01/2011 - 01/2008
2	U 0126 (UO 126)IBA 11/2010 - 02/2010
2	phenethyl isothiocyanate (PEITC)IBA 06/2010 - 01/2009
2	IsothiocyanatesIBA 06/2010 - 01/2009
2	pleiotrophin (HARP)IBA 05/2006 - 01/2002
1	yiki-huoxueIBA 01/2021
1	Capsules (Microcapsules)IBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Plant ExtractsIBA 01/2021
1	Dust (House Dust)FDA Link 11/2016
1	cyclo(Arg-Pro) (CI 4)IBA 11/2016
1	Growth Factor ReceptorsIBA 12/2015
1	Biological ProductsIBA 12/2015
1	Phenobarbital (Luminal)FDA Link 10/2014
1	Mitogen-Activated Protein KinasesIBA 09/2014
1	Furylfuramide (AF2)IBA 01/2014
1	CaspasesIBA 08/2013
1	Propidium (Propidium Iodide)IBA 08/2013
1	Annexin A5IBA 08/2013
1	icaritinIBA 05/2011
1	Steroid Receptors (Steroid Receptor)IBA 01/2011
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2011
1	Cyclin D1IBA 11/2010
1	bisindolylmaleimideIBA 11/2010
1	rottlerinIBA 11/2010
1	Bovine Serum AlbuminIBA 11/2010
1	N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA 11/2010
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2010
1	Fulvestrant (Faslodex)FDA Link 06/2010
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 02/2010
1	Testosterone (Sustanon)FDA Link 09/2009
1	Transcription Factors (Transcription Factor)IBA 01/2008
1	LigandsIBA 01/2008
1	AntibodiesIBA 01/2008
1	Glycogen Synthase Kinase 3 betaIBA 11/2006
1	LuciferasesIBA 11/2006
1	Indicators and Reagents (Reagents)IBA 05/2006
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 05/2006
1	Tetracycline (Achromycin)FDA LinkGeneric 11/2003
1	ChromatinIBA 09/2003
1	Arsenic Trioxide (Trisenox)FDA Link 03/2002
1	MitogensIBA 03/2002

Therapy/Procedure

10	Therapeutics 01/2016 - 04/2010
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021 - 01/2021
1	Intraocular Lenses (Intraocular Lens) 01/2021
1	Radiotherapy 05/2013